YEAR | COMPANY | POSITION | SALARY | INCREMENT |
---|---|---|---|---|
2024 | Prelude Therapeutics Inc | Independent Director | - | - |
2024 | Merus N.V | Independent Director | - | - |
2024 | Kymera Therapeutics Inc | Independent Director | - | - |
2023 | Merus N.V | Independent Director | 303.6 K | 3.8 % |
2023 | Kymera Therapeutics Inc | Independent Director | 231.5 K | - |
2023 | Adc Therapeutics SA | Independent Director | 227.7 K | - |
2023 | Prelude Therapeutics Inc | Independent Director | 131.0 K | -64.8 % |
2022 | Prelude Therapeutics Inc | Independent Director | 372.5 K | -50.3 % |
2022 | Merus N.V | Independent Director | 292.5 K | 79.9 % |
2022 | Kymera Therapeutics Inc | Independent Director | - | - |
2022 | Adc Therapeutics SA | Independent Director | - | - |
2021 | Prelude Therapeutics Inc | Independent Director | 750 K | 269.7 % |
2021 | Merus N.V | Independent Director | 162.6 K | -5.5 % |
2020 | Prelude Therapeutics Inc | Independent Director | 202.9 K | - |
2020 | Merus N.V | Independent Director | 172.0 K | -11.8 % |
2020 | Adc Therapeutics SA | Independent Director | - | - |
2019 | Merus N.V | Director | 195.0 K | - |
2019 | Adc Therapeutics SA | Director | - | - |
2019 | Prelude Therapeutics Inc | Independent Director | - | - |